Report of Foreign Issuer (6-k)
March 22 2016 - 6:03AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2016
Commission File Number: 001-36596
___________________
TRILLIUM THERAPEUTICS INC.
(Translation of registrant's name into English)
96 Skyway Avenue
Toronto, Ontario M9W 4Y9
Canada
(Address of principal executive offices)
___________________
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ ] Form
40-F [X]
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1)[ ]
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7)[ ]
DOCUMENTS FILED AS PART OF THIS FORM 6-K
See the Exhibit Index hereto.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
Trillium Therapeutics Inc. |
|
|
|
|
Date: March 21, 2016 |
|
|
By: /s/ James
Parsons
|
|
Name: James Parsons |
|
Title: Chief Financial Officer
|
2
EXHIBIT INDEX
|
|
|
|
100 University Avenue, 8th floor |
Date: March 21, 2016 |
Toronto ON, M5J 2Y1 |
|
www.computershare.com
|
To: All Canadian Securities Regulatory Authorities
Subject: TRILLIUM THERAPEUTICS INC.
Dear Sir/Madam:
We advise of the following with respect to the upcoming Meeting
of Security Holders for the subject Issuer:
Meeting Type : |
Annual General and Special Meeting |
Record Date for Notice of Meeting : |
April 15, 2016 |
Record Date for Voting (if applicable) : |
April 15, 2016 |
Beneficial Ownership Determination Date : |
April 15, 2016 |
Meeting Date : |
May 27, 2016 |
Meeting Location (if available) : |
Mississauga, ON |
Issuer sending proxy related materials directly to NOBO:
|
No |
Issuer paying for delivery to OBO: |
No |
Notice and Access (NAA) Requirements: |
|
NAA for Beneficial Holders |
Yes |
Beneficial Holders
Stratification Criteria: |
Not Applicable |
NAA for Registered Holders |
Yes |
Registered Holders
Stratification Criteria: |
Not Applicable |
Voting Security Details:
Description |
CUSIP Number |
ISIN |
COMMON SHARES |
89620X506 |
CA89620X5064 |
Sincerely,
Computershare
Agent for
TRILLIUM THERAPEUTICS INC.
Trillium Therapeutics (NASDAQ:TRIL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Trillium Therapeutics (NASDAQ:TRIL)
Historical Stock Chart
From Apr 2023 to Apr 2024